Cy­to­ki­net­ics CEO de­fends Roy­al­ty Phar­ma deal: 'That nar­ra­tive was hi­jacked'

Cy­to­ki­net­ics CEO Robert Blum blamed in­vestor frus­tra­tion over a deal with Roy­al­ty Phar­ma on a “hi­jacked” nar­ra­tive that the com­pa­ny would be bet­ter off sell­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER